Thursday, January 7, 2016

A journal article ask the FDA to defy its own policies concerning compounding and drug importation to combat rising drug prices

Sharfstein: FDA Should Allow Mass Compounding, Drug Imports

Drug Industry Daily
A AA journal article asking the FDA to defy its own policies concerning mass compounding and drug importation to combat rising drug prices comes from an unusual source: the agency’s former second-in-command.

To View This Article:

Login

Subscribe To Drug Industry Daily

No comments: